Global Colloidal Bismuth Pectin Capsules Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Colloidal Bismuth Pectin Capsules Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Colloidal bismuth pectin capsules are capsules made of colloidal bismuth pectin, which is a complex of pectin and bismuth with an indeterminate composition. This product is mainly used to treat gastric ulcer and gastritis.
Colloidal Bismuth Pectin Capsules report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Colloidal Bismuth Pectin Capsules market is projected to reach US$ 66 million in 2029, increasing from US$ 51 million in 2022, with the CAGR of 3.7% during the period of 2024 to 2029. Demand from Stomach Ulcer Treatment and Gastritis Treatment are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Colloidal Bismuth Pectin Capsules industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Colloidal Bismuth Pectin Capsules key manufacturers include China National Pharmaceutical Group Corporation Tongjitang (Guizhou) Pharmaceutical, Shanxi Ante Bio-pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, North China Pharmaceutical Company, Harbin Pharmaceutical Group, Shanxi PUDE Pharmaceutical, Lionco Pharmaceutical Group, Guilin Hwasun Pharmaceutical and Renhe Pharmacy, etc. China National Pharmaceutical Group Corporation Tongjitang (Guizhou) Pharmaceutical, Shanxi Ante Bio-pharmaceutical, Guangzhou Baiyunshan Pharmaceutical are top 3 players and held % sales share in total in 2022.
Colloidal Bismuth Pectin Capsules can be divided into 50mg/Pcs, 100mg/Pcs and Other,, etc. 50mg/Pcs is the mainstream product in the market, accounting for % sales share globally in 2022.
Colloidal Bismuth Pectin Capsules is widely used in various fields, such as Stomach Ulcer Treatment, Gastritis Treatment and Other,, etc. Stomach Ulcer Treatment provides greatest supports to the Colloidal Bismuth Pectin Capsules industry development. In 2022, global % sales of Colloidal Bismuth Pectin Capsules went into Stomach Ulcer Treatment filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Colloidal Bismuth Pectin Capsules market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
China National Pharmaceutical Group Corporation Tongjitang (Guizhou) Pharmaceutical
Shanxi Ante Bio-pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
North China Pharmaceutical Company
Harbin Pharmaceutical Group
Shanxi PUDE Pharmaceutical
Lionco Pharmaceutical Group
Guilin Hwasun Pharmaceutical
Renhe Pharmacy
Guangdong Pidi Pharmaceutical
Lionco Pharmaceutical Group
Gaoyou Zhaokang Pharmaceutical
Sichuan Emeishan Jinding Pharmaceutical
Charoen Pokphand Group
Guizhou Warmen Pharmaceutical
Sichuan Kelun Pharmaceutical
ZHEJIANG DND PHARMACEUTICAL
Luoyang Junshan Pharmaceutical
Anhui Yongshengtang Pharmaceutical Limited Liability Company
SHANGHAI XIANDAI HASEN (SHANGQIU) PHARMACEUTICAL
Segment by Type
50mg/Pcs
100mg/Pcs
Other
Stomach Ulcer Treatment
Gastritis Treatment
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Colloidal Bismuth Pectin Capsules market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Colloidal Bismuth Pectin Capsules, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Colloidal Bismuth Pectin Capsules industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Colloidal Bismuth Pectin Capsules in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Colloidal Bismuth Pectin Capsules introduction, etc. Colloidal Bismuth Pectin Capsules Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Colloidal Bismuth Pectin Capsules market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Colloidal Bismuth Pectin Capsules report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Colloidal Bismuth Pectin Capsules market is projected to reach US$ 66 million in 2029, increasing from US$ 51 million in 2022, with the CAGR of 3.7% during the period of 2024 to 2029. Demand from Stomach Ulcer Treatment and Gastritis Treatment are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Colloidal Bismuth Pectin Capsules industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Colloidal Bismuth Pectin Capsules key manufacturers include China National Pharmaceutical Group Corporation Tongjitang (Guizhou) Pharmaceutical, Shanxi Ante Bio-pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, North China Pharmaceutical Company, Harbin Pharmaceutical Group, Shanxi PUDE Pharmaceutical, Lionco Pharmaceutical Group, Guilin Hwasun Pharmaceutical and Renhe Pharmacy, etc. China National Pharmaceutical Group Corporation Tongjitang (Guizhou) Pharmaceutical, Shanxi Ante Bio-pharmaceutical, Guangzhou Baiyunshan Pharmaceutical are top 3 players and held % sales share in total in 2022.
Colloidal Bismuth Pectin Capsules can be divided into 50mg/Pcs, 100mg/Pcs and Other,, etc. 50mg/Pcs is the mainstream product in the market, accounting for % sales share globally in 2022.
Colloidal Bismuth Pectin Capsules is widely used in various fields, such as Stomach Ulcer Treatment, Gastritis Treatment and Other,, etc. Stomach Ulcer Treatment provides greatest supports to the Colloidal Bismuth Pectin Capsules industry development. In 2022, global % sales of Colloidal Bismuth Pectin Capsules went into Stomach Ulcer Treatment filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Colloidal Bismuth Pectin Capsules market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
China National Pharmaceutical Group Corporation Tongjitang (Guizhou) Pharmaceutical
Shanxi Ante Bio-pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
North China Pharmaceutical Company
Harbin Pharmaceutical Group
Shanxi PUDE Pharmaceutical
Lionco Pharmaceutical Group
Guilin Hwasun Pharmaceutical
Renhe Pharmacy
Guangdong Pidi Pharmaceutical
Lionco Pharmaceutical Group
Gaoyou Zhaokang Pharmaceutical
Sichuan Emeishan Jinding Pharmaceutical
Charoen Pokphand Group
Guizhou Warmen Pharmaceutical
Sichuan Kelun Pharmaceutical
ZHEJIANG DND PHARMACEUTICAL
Luoyang Junshan Pharmaceutical
Anhui Yongshengtang Pharmaceutical Limited Liability Company
SHANGHAI XIANDAI HASEN (SHANGQIU) PHARMACEUTICAL
Segment by Type
50mg/Pcs
100mg/Pcs
Other
Segment by Application
Stomach Ulcer Treatment
Gastritis Treatment
Other
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Colloidal Bismuth Pectin Capsules market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Colloidal Bismuth Pectin Capsules, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Colloidal Bismuth Pectin Capsules industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Colloidal Bismuth Pectin Capsules in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Colloidal Bismuth Pectin Capsules introduction, etc. Colloidal Bismuth Pectin Capsules Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Colloidal Bismuth Pectin Capsules market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices